Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;61(1):15-23.
doi: 10.47162/RJME.61.1.02.

Microfluidic endothelium-on-a-chip development, from in vivo to in vitro experimental models

Affiliations

Microfluidic endothelium-on-a-chip development, from in vivo to in vitro experimental models

Adriana Elena Bulboacă et al. Rom J Morphol Embryol. 2020.

Abstract

In the last years, animal testing in medical research has been a controversial topic because of various reasons, such as ethical considerations and species differences. Therefore, more attention has been given to develop new technologies that can replace animal experiments and create in vitro models. Organ-on-a-chip (OOC) technology is a new and advanced technology based on microfluidic devices that can mimic the structure and function of entire organs and tissues as in vitro models. OOC models are miniature tissues and organs that assign characteristics for three-dimensional (3D) cell culture representation that resemble the original organs, together with their specific microenvironment microfluidic systems and specific biophysical processes, in order to mimic the normal physiological conditions and functionalities of the organs. Existing OOC models, such as liver, pancreas, heart, skin, brain, kidney, vessels, have been developed and designed for a specific function study. This review focuses on the main knowledge concerning OOC research and especially vascular endothelium-on-a-chip (EOC) model, developed in order to offer specific tools for studying vascular functions in physiological and pathological conditions. The field of OOC devices is still at the beginning, but in the future, this technology may have important roles in developing novel therapeutic approaches, offering new therapeutic molecules and providing the first step towards personalized medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interests.

References

    1. Kimura H, Sakai Y, Fujii T. Organ/body-on-a-chip based on microfluidic technology for drug discovery. Drug Metab Pharmacokinet. 2018;33(1):43–48. - PubMed
    1. Caballero D, Kaushik S, Correlo VM, Oliveira JM, Reis RL, Kundu SC. Organ-on-chip models of cancer metastasis for future personalized medicine: from chip to the patient. Biomaterials. 2017;149:98–115. - PubMed
    1. Arrigoni C, Gilardi M, Bersini S, Candrian C, Moretti M. Bioprinting and organ-on-chip applications towards personalized medicine for bone diseases. Stem Cell Rev Rep. 2017;13(3):407–417. - PubMed
    1. Lee SH, Sung JH. Organ-on-a-chip technology for reproducing multiorgan physiology. Adv Healthc Mater. 2018;7(2):1700419–1700419. - PubMed
    1. Zhao Y, Kankala RK, Wang SB, Chen AZ. Multi-organs-on-chips: towards long-term biomedical investigations. Molecules. 2019;24(4):675–675. - PMC - PubMed